Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs ICE vs CME vs WAFD
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Banks - Regional
PROV vs ICE vs CME vs WAFD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Banks - Regional |
| Market Cap | $109M | $79.60B | $97.79B | $2.85B |
| Revenue (TTM) | $60M | $12.64B | $6.76B | $1.39B |
| Net Income (TTM) | $7M | $3.30B | $4.24B | $243M |
| Gross Margin | 67.8% | 61.9% | 86.3% | 52.8% |
| Operating Margin | 16.2% | 38.7% | 65.6% | 22.4% |
| Forward P/E | 15.4x | 17.3x | 22.0x | 11.4x |
| Total Debt | $213M | $20.28B | $3.76B | $1.82B |
| Cash & Equiv. | $53M | $837M | $4.42B | $657M |
PROV vs ICE vs CME vs WAFD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Intercontinental Ex… (ICE) | 100 | 153.4 | +53.4% |
| CME Group Inc. (CME) | 100 | 165.8 | +65.8% |
| WaFd, Inc. (WAFD) | 100 | 138.1 | +38.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs ICE vs CME vs WAFD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.21, yield 3.3%
- Beta 0.21, yield 3.3%, current ratio 0.06x
- NIM 2.8% vs WAFD's 2.5%
- Lower P/E (15.4x vs 17.3x)
ICE is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 7.5%, EPS growth 20.7%
- Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
- 7.5% NII/revenue growth vs WAFD's -1.6%
CME carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 262.4% 10Y total return vs ICE's 195.3%
- PEG 1.60 vs WAFD's 3.69
- Efficiency ratio 0.2% vs PROV's 0.5% (lower = leaner)
- 4.1% yield, 15-year raise streak, vs WAFD's 2.8%
WAFD is the clearest fit if your priority is momentum.
- +32.5% vs ICE's -20.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.5% NII/revenue growth vs WAFD's -1.6% | |
| Value | Lower P/E (15.4x vs 17.3x) | |
| Quality / Margins | Efficiency ratio 0.2% vs PROV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs WAFD's 0.66 | |
| Dividends | 4.1% yield, 15-year raise streak, vs WAFD's 2.8% | |
| Momentum (1Y) | +32.5% vs ICE's -20.4% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs PROV's 0.5% |
PROV vs ICE vs CME vs WAFD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PROV vs ICE vs CME vs WAFD — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CME leads in 3 of 6 categories
PROV leads 0 • ICE leads 0 • WAFD leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICE is the larger business by revenue, generating $12.6B annually — 210.1x PROV's $60M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to PROV's 11.0%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $60M | $12.6B | $6.8B | $1.4B |
| EBITDAEarnings before interest/tax | $12M | $6.5B | $4.7B | $277M |
| Net IncomeAfter-tax profit | $7M | $3.3B | $4.2B | $243M |
| Free Cash FlowCash after capex | $9M | $4.3B | $4.4B | $215M |
| Gross MarginGross profit ÷ Revenue | +67.8% | +61.9% | +86.3% | +52.8% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +38.7% | +65.6% | +22.4% |
| Net MarginNet income ÷ Revenue | +11.0% | +26.1% | +62.8% | +17.5% |
| FCF MarginFCF ÷ Revenue | +15.3% | +33.9% | +64.4% | +15.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | +23.1% | +21.4% | +46.3% |
Valuation Metrics
Evenly matched — PROV and WAFD each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 14.1x trailing earnings, WAFD trades at a 42% valuation discount to ICE's 24.4x P/E. Adjusting for growth (PEG ratio), CME offers better value at 1.76x vs WAFD's 4.58x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $109M | $79.6B | $97.8B | $2.9B |
| Enterprise ValueMkt cap + debt − cash | $269M | $99.0B | $97.1B | $4.0B |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 24.36x | 24.15x | 14.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 17.34x | 21.98x | 11.35x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.74x | 1.76x | 4.58x |
| EV / EBITDAEnterprise value multiple | 21.77x | 15.34x | 21.56x | 13.41x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 6.30x | 15.00x | 2.02x |
| Price / BookPrice ÷ Book value/share | 0.90x | 2.77x | 3.38x | 0.98x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 18.56x | 23.32x | 13.71x |
Profitability & Efficiency
CME leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CME delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $5 for PROV. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to PROV's 1.66x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CME's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +11.6% | +15.3% | +8.0% |
| ROA (TTM)Return on assets | +0.5% | +2.3% | +2.2% | +0.9% |
| ROICReturn on invested capital | +1.9% | +7.5% | +10.2% | +3.9% |
| ROCEReturn on capital employed | +2.4% | +9.5% | +3.6% | +5.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 9 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.66x | 0.70x | 0.13x | 0.60x |
| Net DebtTotal debt minus cash | $160M | $19.4B | -$666M | $1.2B |
| Cash & Equiv.Liquid assets | $53M | $837M | $4.4B | $657M |
| Total DebtShort + long-term debt | $213M | $20.3B | $3.8B | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 6.53x | 41.55x | 0.48x |
Total Returns (Dividends Reinvested)
CME leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CME five years ago would be worth $14,623 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, WAFD leads with a +32.5% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors CME at 18.9% vs ICE's 10.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | -11.8% | +3.2% | +17.1% |
| 1-Year ReturnPast 12 months | +14.5% | -20.4% | +3.6% | +32.5% |
| 3-Year ReturnCumulative with dividends | +50.9% | +34.6% | +67.9% | +37.6% |
| 5-Year ReturnCumulative with dividends | +18.2% | +30.9% | +46.2% | +29.5% |
| 10-Year ReturnCumulative with dividends | +25.8% | +195.3% | +262.4% | +91.9% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +10.4% | +18.9% | +11.2% |
Risk & Volatility
Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than WAFD's 0.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAFD currently trades 99.9% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.35x | -0.28x | 0.66x |
| 52-Week HighHighest price in past year | $17.42 | $189.35 | $329.16 | $37.10 |
| 52-Week LowLowest price in past year | $14.95 | $136.67 | $244.56 | $26.31 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +74.2% | +81.9% | +99.9% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 31.9 | 40.1 | 63.8 |
| Avg Volume (50D)Average daily shares traded | 8K | 3.2M | 2.6M | 525K |
Analyst Outlook
Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", ICE as "Buy", CME as "Hold", WAFD as "Hold". Consensus price targets imply 38.0% upside for ICE (target: $194) vs -6.5% for PROV (target: $16). For income investors, CME offers the higher dividend yield at 4.05% vs ICE's 1.38%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $16.00 | $194.00 | $320.80 | $35.00 |
| # AnalystsCovering analysts | 10 | 36 | 36 | 11 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +1.4% | +4.1% | +2.8% |
| Dividend StreakConsecutive years of raises | 0 | 13 | 15 | 16 |
| Dividend / ShareAnnual DPS | $0.56 | $1.93 | $10.92 | $1.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +1.7% | +0.3% | +3.6% |
CME leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
PROV vs ICE vs CME vs WAFD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or ICE or CME or WAFD a better buy right now?
For growth investors, Intercontinental Exchange, Inc.
(ICE) is the stronger pick with 7. 5% revenue growth year-over-year, versus -1. 6% for WaFd, Inc. (WAFD). WaFd, Inc. (WAFD) offers the better valuation at 14. 1x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or ICE or CME or WAFD?
On trailing P/E, WaFd, Inc.
(WAFD) is the cheapest at 14. 1x versus Intercontinental Exchange, Inc. at 24. 4x. On forward P/E, WaFd, Inc. is actually cheaper at 11. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CME Group Inc. wins at 1. 60x versus WaFd, Inc. 's 3. 69x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PROV or ICE or CME or WAFD?
Over the past 5 years, CME Group Inc.
(CME) delivered a total return of +46. 2%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: CME returned +262. 4% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or ICE or CME or WAFD?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 28β versus WaFd, Inc. 's 0. 66β — meaning WAFD is approximately -336% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 166% for Provident Financial Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or ICE or CME or WAFD?
By revenue growth (latest reported year), Intercontinental Exchange, Inc.
(ICE) is pulling ahead at 7. 5% versus -1. 6% for WaFd, Inc. (WAFD). On earnings-per-share growth, the picture is similar: Intercontinental Exchange, Inc. grew EPS 20. 7% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or ICE or CME or WAFD?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 14. 8% for PROV. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or ICE or CME or WAFD more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CME Group Inc. (CME) is the more undervalued stock at a PEG of 1. 60x versus WaFd, Inc. 's 3. 69x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, WaFd, Inc. (WAFD) trades at 11. 4x forward P/E versus 22. 0x for CME Group Inc. — 10. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.
08Which pays a better dividend — PROV or ICE or CME or WAFD?
All stocks in this comparison pay dividends.
CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 4% for Intercontinental Exchange, Inc. (ICE).
09Is PROV or ICE or CME or WAFD better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). Both have compounded well over 10 years (CME: +262. 4%, WAFD: +91. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and ICE and CME and WAFD?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock; WAFD is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.